Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation

Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis

(2014) S. J. Caillier et al.   JOURNAL OF IMMUNOLOGY

Matrix Metalloproteinase-7 and Matrix Metalloproteinase-9 in Pediatric Multiple Sclerosis

(2012) Yılmaz Ünsal et al.   PEDIATRIC NEUROLOGY

AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β

(2012) Megan L. Mittelstadt et al.   PLoS One

Genome-wide association studies in multiple sclerosis: lessons and future prospects

(2011) A. Kemppinen et al.   Briefings in Functional Genomics

Subcutaneous Recombinant Interferon-β-1a (Rebif®)

(2011) Mark Sanford et al.   DRUGS

How do immune cells overcome the blood-brain barrier in multiple sclerosis?

(2011) Catherine Larochelle et al.   FEBS LETTERS

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Systematic review of genome-wide expression studies in multiple sclerosis

(2011) A. K. Kemppinen et al.   BMJ Open

Glatiramer Acetate

(2010) Natalie J. Carter et al.   DRUGS

Current and future disease-modifying therapies in multiple sclerosis

(2010) S. Y. Lim et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

IFN-  Inhibits Dendritic Cell Migration through STAT-1-Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9

(2010) J.-H. Yen et al.   JOURNAL OF IMMUNOLOGY

Differential Gene Expression and Translational Approaches to Identify Biomarkers of Interferon Beta Activity in Multiple Sclerosis

(2010) Ed Croze   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Gene expression profiling in multiple sclerosis brain

(2010) Ranjan Dutta et al.   NEUROBIOLOGY OF DISEASE

Matrix Metalloproteinases and Neurotrauma: Evolving Roles in Injury and Reparative Processes

(2010) Haoqian Zhang et al.   NEUROSCIENTIST

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

(2009) Eva Havrdova et al.   LANCET NEUROLOGY

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

(2009) Philip L De Jager et al.   NATURE GENETICS

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

(2008) Manuel Comabella et al.   CLINICAL IMMUNOLOGY

Assessing RNA quality in postmortem human brain tissue

(2007) Ia Chevyreva et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY